BHA‐CS: A novel cognitive composite for Alzheimer's disease and related disorders
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring2020Vol. 12(1), pp. e12042–e12042
Citations Over TimeTop 10% of 2020 papers
Elena Tsoy, Sabrina J. Erlhoff, Collette A. Goode, Karen A. Dorsman, Suchanan Kanjanapong, Cutter A. Lindbergh, Renaud La Joie, Amelia Strom, Gil D. Rabinovici, Serggio Lanata, Bruce L. Miller, Sarah Tomaszewski Farias, Joel H. Kramer, Katherine P. Rankin, Katherine L. Possin
Abstract
The BHA-CS is sensitive to cognitive decline in preclinical and prodromal neurodegenerative disease.
Related Papers
- → Analyzing the chance of developing dementia among geriatric people: a cross‐sectional pilot study in Bangladesh(2018)48 cited
- → Dementia Risk Prediction: Are We There Yet?(2010)18 cited
- → Reversible Dementia and the Misdiagnosis of Dementia: A Review(1983)29 cited
- Survey of Dementia Awareness and Needs in Seongdong-gu Regional Center for Dementia(2008)
- [The incidence of reversible dementia in 145 patients referred on suspicion of dementia].(2002)